Literature DB >> 26823867

TNF-α and IL10 polymorphisms interaction increases the risk of ankylosing spondylitis in Chinese Han population.

Nai-Guo Wang1, Da-Chuan Wang1, Bing-Yi Tan1, Feng Wang1, Ze-Nong Yuan1.   

Abstract

AIMS: The target of this article was to reveal the role of tumor necrosis factors α (TNF-α) and Interleukin-10 (IL10) gene polymorphisms in ankylosing spondylitis (AS) development and explore the interaction between these two gene polymorphisms.
METHODS: The genotyping of gene polymorphims was conducted using ABI Taqman assay method in 84 AS patients and 92 healthy people. Hardy-Weinberg equilibrium (HWE) was checked in the control group and the genotypes and alleles difference were compared with χ(2) test. Odds ratio (OR) with 95% confidence interval (CI) was calculated to identify the strength of association between gene polymorphism and disease. Meanwhile, multifactor dimensionality reduction (MDR) method was used to analysis the interaction between gene polymorphisms.
RESULTS: The genotypes CG+CC of the minor allele in IL10 rs1878672 in cases was obviously higher frequency than the controls (P=0.03) and the minor allele C was also associated with the increased risk of AS, compared with G allele (OR=2.05, 95% CI=1.08-3.89). Rs3024490 in IL10 also showed a significant correlation to the onset risk of AS (GG vs. TT: OR=3.03, 95% CI=1.04-8.87; G vs. T: OR=1.70, 95% CI=1.08-2.68). What's more, there was the interaction between TNF-α rs3093662 and IL10 rs3021094, rs3024490 polymorphisms in AS.
CONCLUSIONS: IL10 rs1878672 and rs3024490 polymorphisms obviously increase the susceptibility to AS, but not TNF-α rs3093662. Both IL10 and TNF-α polymorphisms may affect the onset of AS.

Entities:  

Keywords:  IL10; TNF-α; ankylosing spondylitis; interaction; polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26823867      PMCID: PMC4713653     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  28 in total

1.  Segregation of HL-A27 and ankylosing spondylitis in an informative kindred.

Authors:  M de Bruyère; C Nagent de Deuxchaisnes
Journal:  Tissue Antigens       Date:  1976-01

2.  TNF-α-308G/A polymorphism associated with TNF-α protein expression in patients with diabetic nephropathy.

Authors:  Yan Peng; Liu-Juan Li
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  Whole body hyperthermia treatment increases interleukin 10 and toll-like receptor 4 expression in patients with ankylosing spondylitis: a pilot study.

Authors:  Dorothea Zauner; Franz Quehenberger; Josef Hermann; Christian Dejaco; Martin H Stradner; Tatjana Stojakovic; Hannes Angerer; Beate Rinner; Winfried B Graninger
Journal:  Int J Hyperthermia       Date:  2014-09       Impact factor: 3.914

4.  Association of KIF21B genetic polymorphisms with ankylosing spondylitis in a Chinese Han population of Shandong Province.

Authors:  Xinglin Yang; Ming Li; Liya Wang; Zhongdan Hu; Yuanchao Zhang; Qingrui Yang
Journal:  Clin Rheumatol       Date:  2014-08-23       Impact factor: 2.980

Review 5.  [Tumor necrosis factor alpha genetic polymorphism as a risk factor in disease].

Authors:  Juan C Aguillón; Andrea Cruzat; Jimena Cuenca; Miguel Cuchacovich
Journal:  Rev Med Chil       Date:  2002-09       Impact factor: 0.553

6.  Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa.

Authors:  C J Edwards-Smith; J R Jonsson; D M Purdie; A Bansal; C Shorthouse; E E Powell
Journal:  Hepatology       Date:  1999-08       Impact factor: 17.425

7.  Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases.

Authors:  R J François; L Neure; J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2005-10-25       Impact factor: 19.103

8.  HLA-B27 subtypes and tumor necrosis factor alpha promoter region polymorphism in Iranian patients with ankylosing spondylitis.

Authors:  Mohammad Hossein Nicknam; Mahdi Mahmoudi; Ali Akbar Amirzargar; Ahmad Reza Jamshidi; Nima Rezaei; Behrouz Nikbin
Journal:  Eur Cytokine Netw       Date:  2009-03       Impact factor: 2.737

9.  Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after kidney transplantation.

Authors:  Ajay K Israni; Na Li; Bojana B Cizman; Jon Snyder; John Abrams; Marshall Joffe; Timothy Rebbeck; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2008-08       Impact factor: 8.860

10.  Ankylosing spondylitis is associated with the anthrax toxin receptor 2 gene (ANTXR2).

Authors:  T Karaderi; S M Keidel; J J Pointon; L H Appleton; M A Brown; D M Evans; B P Wordsworth
Journal:  Ann Rheum Dis       Date:  2014-08-28       Impact factor: 19.103

View more
  4 in total

Review 1.  The association of polymorphisms in TNF and ankylosing spondylitis in common population: a meta-analysis.

Authors:  Huae Shu; Hongsheng Sun; Naiwen Hu; Xi Chen; Shanjuan Wang; Gangying Yuan; Qinqin Wang
Journal:  Eur Spine J       Date:  2021-04-20       Impact factor: 3.134

Review 2.  Lack of association between TNF polymorphism and ankylosing spondylitis susceptibility in HLA-B27-positive population: a meta-analysis.

Authors:  Yanyan Bai; Hongsheng Sun; Naiwen Hu; Dongxia Liu; Na Zhao; Xia Wang
Journal:  Eur Spine J       Date:  2021-06-08       Impact factor: 3.134

3.  Single nucleotide polymorphisms of TRAF2 and TRAF5 gene in ankylosing spondylitis: a case-control study.

Authors:  Shanshan Xu; Jiangping Kong; Li Huang; Huimin Xie; Feier Wang; Tingting Zhou; Xiaoyi Zhang; Lingxiang Yu; Shengqian Xu; Faming Pan
Journal:  Clin Exp Med       Date:  2021-05-17       Impact factor: 3.984

4.  Ankylosing spondylitis risk factors: a systematic literature review.

Authors:  Mark C Hwang; Lauren Ridley; John D Reveille
Journal:  Clin Rheumatol       Date:  2021-03-22       Impact factor: 3.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.